Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort

BackgroundThe subcutaneous implantable cardioverter-defibrillator (S-ICD) has been designed to overcome lead-related complications and device endocarditis. Lacking the ability for pacing or resynchronization therapy its usage is limited to selected patients at risk for sudden cardiac death (SCD).Obj...

Full description

Bibliographic Details
Published in:Frontiers in Cardiovascular Medicine
Main Authors: Badder Kattih, Felix Operhalski, Felicitas Boeckling, Florian Hecker, Felix Michael, Mate Vamos, Stefan H. Hohnloser, Julia W. Erath
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1008311/full